Immunoassays: A $27 Billion Market of Intrigue and Opportunity
The global market for lab-based immunoassays, inclusive of both infectious disease and non-infectious disease analytes and instruments, reached $27 billion in 2023 and is forecast to experience modest growth in the foreseeable future. The findings are based on data published in In Vitro Diagnostics Business Outlook, 2024, a bi-monthly newsletter focused on global IVD products […]